Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase IV study of Sedron 70 mg in men with osteoporosis and kidney stones
2005-002780-82Phase 4Completed
- Sponsor
- Gedeon Richter Plc
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of risedronate in osteoporosis, sponsored by Gedeon Richter Plc. Primary endpoint: Change in bone mineral density. Started Jun 2005; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2005-002780-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002780-82.